NOV: NOVOBIOCIN
NOV is a Ligand Of Interest in 4URO designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
4URO_NOV_A_2000 | 70% | 55% | 0.151 | 0.97 | 0.82 | 0.93 | 2 | 4 | 0 | 0 | 100% | 1 |
4URO_NOV_B_2000 | 68% | 54% | 0.154 | 0.965 | 0.84 | 0.92 | 2 | 3 | 0 | 0 | 100% | 1 |
4URO_NOV_C_2000 | 58% | 59% | 0.172 | 0.951 | 0.67 | 0.91 | 2 | 2 | 2 | 0 | 100% | 1 |
4URO_NOV_D_2000 | 47% | 53% | 0.186 | 0.927 | 0.89 | 0.94 | 2 | 4 | 0 | 0 | 100% | 1 |
6Y8O_NOV_B_301 | 96% | 53% | 0.063 | 0.974 | 0.76 | 1.05 | - | 3 | 0 | 0 | 100% | 1 |
7PTF_NOV_B_301 | 94% | 58% | 0.066 | 0.967 | 0.72 | 0.9 | 2 | 3 | 0 | 0 | 100% | 1 |
6Y8L_NOV_A_501 | 82% | 55% | 0.108 | 0.963 | 0.81 | 0.91 | 1 | 4 | 0 | 0 | 100% | 0.5 |
7PQI_NOV_A_301 | 78% | 57% | 0.109 | 0.951 | 0.69 | 0.95 | 1 | 4 | 0 | 0 | 100% | 1 |
6B89_NOV_B_403 | 75% | 78% | 0.118 | 0.952 | 0.29 | 0.6 | - | 1 | 2 | 0 | 100% | 1 |